17β-estradiol inhibition of NADPH oxidase expression in human endothelial cells

FASEB Journal

Volumn 15, Issue 12, 2001, Pages 2121-2130

  Wagner, Andreas H ^a   Schroeter, Marco R ^a   Hecker, Markus ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

CD54; Endothelial nitric oxide synthase; Estrogen; Monocyte chemoattractant protein 1; Superoxide

Indexed keywords

ESTRADIOL; INTERCELLULAR ADHESION MOLECULE 1; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE SYNTHASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE; CYBB PROTEIN, HUMAN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ESTROGEN RECEPTOR; HEAT SHOCK PROTEIN 90; MEMBRANE PROTEIN; NOS3 PROTEIN, HUMAN; RNA;

ARTICLE; ATHEROGENESIS; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME INHIBITION; ESTROGEN METABOLISM; FEMALE; HUMAN; HUMAN CELL; NEWBORN; OXIDATIVE STRESS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; ARTERIOSCLEROSIS; BIOSYNTHESIS; CELL CULTURE; CELL LINE; DOWN REGULATION; DRUG EFFECT; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; PHYSIOLOGY; VASCULAR ENDOTHELIUM;

ARTERIOSCLEROSIS; CELL LINE; CELLS, CULTURED; CHEMOKINE CCL2; DOWN-REGULATION; ENDOTHELIUM, VASCULAR; ESTRADIOL; FEMALE; HSP90 HEAT-SHOCK PROTEINS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MEMBRANE GLYCOPROTEINS; NADPH OXIDASE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; REACTIVE OXYGEN SPECIES; RECEPTORS, ESTROGEN; RNA; SUPEROXIDES; TRANSCRIPTION, GENETIC;

EID: 0034811899     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.01-0123com     Document Type: Article

References (52)

1. Hormone therapy to prevent disease and prolong life in postmenopausal women
2. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study
3. Ovarian sex steroids and atherosclerosis
4. The role of nitric oxide in coronary vascular effects of estrogen in postmenopausal women
5. Estrogen receptor α mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen
6. Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the PI3-kinase-Akt pathway in human endothelial cells
7. Estrogen upregulates endothelial nitric oxide synthase gene expression in fetal pulmonary artery endothelium
8. Gender and transcriptional regulation of NO synthase and ET-1 in porcine aortic endothelial cells
9. The endothelium in coronary artery, disease
10. A proposed mechanism for the cardioprotective effect of estrogen in women: Enhanced endothelial nitric oxide release decreases coronary artery reactivity
11. Endothelial dysfunction in atherosclerosis
12. NAD(P)H oxidase: Role in cardiovascular biology and disease
13. Identification of a functional leukocyte-type NADPH oxidase in human endothelial cells: A potential atherogenic source of reactive oxygen species
14. A central role for the endothelial NADPH oxidase in atherosclerosis
15. CD154 stimulation of interleukin-12 synthesis in human endothelial cells
16. Decoy oligodeoxynucleotide characterization of transcription factors controlling endothelin-B receptor expression in vascular smooth muscle cells
17. Subcellular localization and characterization of nitric oxide synthase(s) in endothelial cells: Physiological implications
18. Topological mapping of neutrophil cytochrome b epitopes with phage-display libraries
19. Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation
20. Endothelium-derived hyperpolarizing factor synthase (cytochrome P450 2C9) is a functionally significant source of reactive oxygen species in coronary arteries
21. Inhibition of NADPH oxidase activation by 4-(2-amino-ethyl)-benzenesulfonyl fluoride and related compounds
22. Complete and reversible inhibition of NADPH oxidase in human neutrophils by phenylarsine oxide at a step distal to membrane translocation of the enzyme subunits
23. Vascular estrogen receptors and endothelium-derived nitric oxide production in the mouse aorta. Gender difference and effect of estrogen receptor gene disruption
24. Estrogen increases eNOS and NOx release in human coronary artery endothelium
25. A gp91phox containing NADPH oxidase selectively expressed in endothelial cells is a major source of oxygen radical generation in the arterial wall
26. Biology of nitric oxide signaling
27. Mechanisms of estrogen action in the cardiovascular system
28. Pitfalls of using lucigenin in endothelial cells: Implications for NAD(P)H dependent superoxide formation
29. 2,7-Dihydrodichlorofluorescein diacetate as a fluorescent marker for peroxynitrite formation
30. Analysis of activation-induced conformational changes in p47phox using tryptophan fluorescence spectroscopy
31. Studies on the inhibitory mechanism of iodonium compounds with special reference to neutrophil NADPH oxidase
32. Oscillatory and steady laminar shear stress differentially affect human endothelial redox state: Role of a superoxide-producing NADH oxidase
33. Molecular characterization and localization of the NAD(P)H oxidase components gp91-phox and p22-phox in endothelial cells
34. The molecular basis of chronic granulomatous disease
35. Estrogen stimulates heat shock protein 90 binding to endothelial nitric oxide synthase in human vascular endothelial cells. Effects on calcium sensitivity and NO release
36. ICI 182,780 (Faslodex): Development of a novel, 'pure' antiestrogen
37. Identification of authentic estrogen receptor in cultured endothelial cells. A potential mechanism for steroid hormone regulation of endothelial function
38. Estrogen-receptor-mediated inhibition of human endothelial cell apoptosis. Estradiol as a survival factor
39. Human umbilical vessels and cultured umbilical vein endothelial and smooth muscle cells lack detectable protein and mRNA encoding estrogen receptors
40. Human umbilical vein endothelial cells lack expression of the estrogen receptor
41. Nongenomic stimulation of nitric oxide release by estrogen is mediated by estrogen receptor α localized in caveolae
42. Nongenomic, ER-mediated activation of endothelial nitric oxide synthase: How does it work? What does it mean?
43. Estrogen receptor null mice: What have we learned and where will they lead us?
44. Coronary risk factors, endothelial function, and atherosclerosis: A review
45. Mechanisms responsible for endothelial dysfunction associated with acute estrogen deprivation in normotensive women
46. In vitro effects of different steroid hormones on superoxide anion production of human neutrophil granulocytes
47. Estradiol increases rat aorta endothelium-derived relaxing factor (EDRF) activity without changes in endothelial NO synthase gene expression: Possible role of decreased endothelium-derived superoxide anion production
48. Phlogose und thrombose im gefäβsystem
49. Nitric oxide modulates the expression of monocyte chemoattractant protein 1 in cultured human endothelial cells
50. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines
51. Cyclic strain-induced monocyte chemotactic protein-1 gene expression in endothelial cells involves reactive oxygen species activation of activator protein 1
52. Cyclic strain-induced reactive oxygen species involved in ICAM-1 gene induction in endothelial cells